
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nitazenes—heralding a second wave for the UK drug-related death crisis?
Adam Holland, Caroline S. Copeland, Gillian W. Shorter, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 2, pp. e71-e72
Open Access | Times Cited: 34
Adam Holland, Caroline S. Copeland, Gillian W. Shorter, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 2, pp. e71-e72
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
The public health risks of counterfeit pills
Joseph Friedman, Daniel Ciccarone
The Lancet Public Health (2025) Vol. 10, Iss. 1, pp. e58-e62
Open Access | Times Cited: 1
Joseph Friedman, Daniel Ciccarone
The Lancet Public Health (2025) Vol. 10, Iss. 1, pp. e58-e62
Open Access | Times Cited: 1
Nitazenes represent a growing threat to public health in Europe
Isabelle Giraudon, Katri Abel‐Ollo, Diāna Vanaga-Arāja, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 4, pp. e216-e216
Open Access | Times Cited: 11
Isabelle Giraudon, Katri Abel‐Ollo, Diāna Vanaga-Arāja, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 4, pp. e216-e216
Open Access | Times Cited: 11
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 7
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 7
Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BAR
Fatemeh Chalabianloo, Lars Thore Fadnes, Jörg Aßmus, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
Fatemeh Chalabianloo, Lars Thore Fadnes, Jörg Aßmus, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh
James Nicholls, Wendy Masterton, Danilo Falzon, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
James Nicholls, Wendy Masterton, Danilo Falzon, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
'Zombie drugs': Dehumanising news frames and public stigma towards people who use drugs
Harry Sumnall, A.J.A. Holland, AM Atkinson, et al.
International Journal of Drug Policy (2025) Vol. 136, pp. 104714-104714
Open Access
Harry Sumnall, A.J.A. Holland, AM Atkinson, et al.
International Journal of Drug Policy (2025) Vol. 136, pp. 104714-104714
Open Access
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk
Caroline S. Copeland
Addiction (2025)
Open Access
Caroline S. Copeland
Addiction (2025)
Open Access
Mortality After Prison Release in England and Wales, 2019-2021: A Comparative Analysis of Cause-Specific Death Rates and Risk Profiles
Karen Slade, Lucy V. Justice, Thom Baguley, et al.
Social Science & Medicine (2025) Vol. 369, pp. 117821-117821
Closed Access
Karen Slade, Lucy V. Justice, Thom Baguley, et al.
Social Science & Medicine (2025) Vol. 369, pp. 117821-117821
Closed Access
A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?
Basak Tas, Nicola J. Kalk, Edward Chesney, et al.
Addiction (2025)
Open Access
Basak Tas, Nicola J. Kalk, Edward Chesney, et al.
Addiction (2025)
Open Access
Utilization of drug checking services in Austria: a cross-sectional online survey
Alexandra Karden, Tobias Schiffler, Cornelia Feichtinger, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
Alexandra Karden, Tobias Schiffler, Cornelia Feichtinger, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
Identification of nitazene‐related deaths in Australia: How do we make it accurate and timely?
Jennifer Schumann, Jeremy Dwyer, Jared A Brown, et al.
Drug and Alcohol Review (2025)
Closed Access
Jennifer Schumann, Jeremy Dwyer, Jared A Brown, et al.
Drug and Alcohol Review (2025)
Closed Access
Field-Portable Device for Detection of Controlled and Psychoactive Substances from e-Cigarettes
Matthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
ACS Omega (2025)
Open Access
Matthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
ACS Omega (2025)
Open Access
The UHPLC-MS/MS method for the determination of 26 synthetic benzimidazole opioids (nitazene analogs) with isomers separation
Olga Wachełko, Kaja Tusiewicz, Paweł Szpot, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116796-116796
Closed Access
Olga Wachełko, Kaja Tusiewicz, Paweł Szpot, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116796-116796
Closed Access
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries
Richard Bade, Dhayaalini Nadarajan, Wayne Hall, et al.
Addiction (2025)
Open Access
Richard Bade, Dhayaalini Nadarajan, Wayne Hall, et al.
Addiction (2025)
Open Access
(Dealing with) Illegal Drugs and “Unwanted Land-Use”: A Socially Inclusive Future Planning Imagination for Drug Consumption Rooms
Philip Boland, Tristan Sturm, Gillian W. Shorter
Journal of Planning Education and Research (2025)
Closed Access
Philip Boland, Tristan Sturm, Gillian W. Shorter
Journal of Planning Education and Research (2025)
Closed Access
Commentary on Copeland et al.: Does xylazine in the United Kingdom foreshadow a European synthetic polysubstance drug crisis?
Joseph Friedman
Addiction (2024) Vol. 119, Iss. 7, pp. 1310-1312
Open Access | Times Cited: 4
Joseph Friedman
Addiction (2024) Vol. 119, Iss. 7, pp. 1310-1312
Open Access | Times Cited: 4
The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks
N. E. B. Killeen, Rodney Lakes, M.H. Webster, et al.
Addiction (2024) Vol. 119, Iss. 9, pp. 1657-1658
Open Access | Times Cited: 3
N. E. B. Killeen, Rodney Lakes, M.H. Webster, et al.
Addiction (2024) Vol. 119, Iss. 9, pp. 1657-1658
Open Access | Times Cited: 3
Testing for protonitazene in human hair using LC–MS-MS
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 8, pp. 630-635
Closed Access | Times Cited: 3
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 8, pp. 630-635
Closed Access | Times Cited: 3
Identification of 5-aminometonitazene and 5-acetamidometonitazene in a postmortem case: are nitro-nitazenes unstable?
Claire Parks, Peter Maskell, Denise A. McKeown, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 9, pp. 691-700
Closed Access | Times Cited: 3
Claire Parks, Peter Maskell, Denise A. McKeown, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 9, pp. 691-700
Closed Access | Times Cited: 3
Associations among drug acquisition and use behaviors, psychosocial attributes, and opioid-involved overdoses
James A. Swartz, Peipei Zhao, Ross Jacobucci, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
James A. Swartz, Peipei Zhao, Ross Jacobucci, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Automated detection of controlled substances from sealed e-cigarettes.
Matthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
(2024)
Open Access | Times Cited: 2
Matthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
(2024)
Open Access | Times Cited: 2
Reframing Dutch drug policies: a new era for harm reduction
Machteld Busz, Katrin Schiffer, Ancella Voets, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Machteld Busz, Katrin Schiffer, Ancella Voets, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
A field-portable technology for illicit drug discrimination via deep learning of hybridized reflectance/fluorescence spectro-scopic fingerprints
Alexander Power, Matthew Gardner, Rachael Andrews, et al.
(2024)
Open Access | Times Cited: 1
Alexander Power, Matthew Gardner, Rachael Andrews, et al.
(2024)
Open Access | Times Cited: 1
Europe must continue to lead on harm reduction
B. Kahn, Michel D. Kazatchkine
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
B. Kahn, Michel D. Kazatchkine
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Illegal synthetic opioids: Can Europe prevent a crisis?
Mafalda Pardal, Elle Wadsworth, Beau Kilmer
RAND Corporation eBooks (2024)
Open Access | Times Cited: 1
Mafalda Pardal, Elle Wadsworth, Beau Kilmer
RAND Corporation eBooks (2024)
Open Access | Times Cited: 1